Diagnostics Company BillionToOne Valued At $5.8 Billion In Public Offering

BillionToOne’s shares soared on its first day of trading, giving the company a market cap of $5.8 billion.

Oguzhan Atay, a Turkish immigrant with a Ph.D. in systems biology from Stanford University,…

Continue Reading


News Source: www.forbes.com

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *